Foot & Ankle Orthopaedics (Oct 2020)

Mid- to Long-term Follow-up of Total Ankle Arthroplasty using Salto Talaris Implant

  • Chelsea S. Mathews MD,
  • James S. Davitt MD,
  • J. Chris Coetzee MD,
  • Daniel Norvell PhD,
  • William R. Ledoux PhD,
  • Bruce J. Sangeorzan MD

DOI
https://doi.org/10.1177/2473011420S00349
Journal volume & issue
Vol. 5

Abstract

Read online

Category: Ankle; Ankle Arthritis Introduction/Purpose: Total ankle arthroplasty (TAA) continues to be investigated as a primary treatment for end-stage ankle arthritis. The objective of this study was to report mid- to long-term results of the Salto Talaris TAA using patient reported outcomes and retention rates with mid- to long-term follow up. Methods: This was a multicenter retrospective study using prospectively collected data. 316 patients received a Salto Talaris TAA at one of three institutions from 2005-2015 were included in the study. Outcomes included subdomain scores of the SF-36 (bodily pain and physical function) and adverse events including additional surgeries or revision/removal of components. Results: Statistically significant improvements were seen in pain and physical function scores at 2 year follow up and were maintained through most recent follow-up. Retention rate of the prosthesis was >95% in all patients (30/32 at > 10 years, 272/284 at 4.5-10 years). 14 patients underwent revision or removal of prosthesis. 15 patients had additional surgery that did not involve revision or removal of components. Conclusion: Treatment of end-stage ankle arthritis with the Salto Talaris implant provides patients with improved pain and functional outcome scores in long-term follow up. Low revision rates demonstrate the durability of this prosthesis.